<html>
<head>PUBMED IDs for iRhom2</head>
<body bgcolor='#C5F0F2'><h1>iRhom2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22265016/'>RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.</a> June 20  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24825892/'>Rhbdf2 mutations increase its protein stability and drive EGFR hyperactivation through enhanced secretion of amphiregulin.</a> September 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25546423/'>iRhom2 mutation leads to aberrant hair follicle differentiation in mice.</a> September 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27330189/'>MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.</a> June 23  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27330106/'>Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head.</a> June 23  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28132838/'>Human Cytomegalovirus Tegument Protein UL82 Inhibits STING-Mediated Signaling to Evade Antiviral Immunity.</a> January 31  2017<br></body></html>
